Question

Difficulty: HardPediatric Hematology and Oncology

A 5-year-old boy is brought to the emergency department by his parents due to extreme fatigue, decreased urination over the past 24 hours, and a new rash. One week ago, he had a 3-day episode of severe, bloody diarrhea accompanied by abdominal cramps, which was treated with oral ciprofloxacin at an urgent care clinic. Today, he appears pale and lethargic. Vitals show a temperature of 37.2∘C37.2^\circ\text{C}, heart rate of 135/min135/\text{min}, respiratory rate of 24/min24/\text{min}, and blood pressure of 118/78 mmHg118/78 \text{ mmHg}. Physical examination reveals scleral icterus and scattered petechiae over the lower extremities. The abdomen is soft and non-tender with no hepatosplenomegaly. Laboratory studies show:

Laboratory StudyResult
Hemoglobin6.8 g/dL6.8 \text{ g/dL}
Platelets38,000/mm338,000/\text{mm}^3
Leukocytes14,500/mm314,500/\text{mm}^3
Blood Urea Nitrogen (BUN)52 mg/dL52 \text{ mg/dL}
Creatinine2.4 mg/dL2.4 \text{ mg/dL}

A peripheral blood smear demonstrates numerous fragmented red blood cells. Which of the following is the most appropriate next step in the management of this patient?

  1. Supportive care with intravenous fluid resuscitation and close monitoringAnswer
  2. B
    Intravenous ceftriaxone therapy
  3. C
    Platelet transfusion
  4. D
    Plasma exchange (plasmapheresis)
  5. E
    High-dose intravenous corticosteroids

Answer

The most appropriate next step in management is supportive care with intravenous fluid resuscitation and close monitoring.
Supportive care with intravenous fluid resuscitation and close monitoring is the correct management. The patient's presentation of microangiopathic hemolytic anemia (schistocytes, low hemoglobin, jaundice), thrombocytopenia (petechiae), and acute kidney injury (oliguria, elevated BUN/creatinine) following a bloody diarrheal illness is the classic triad of Hemolytic Uremic Syndrome (HUS). This condition is most commonly caused by Shiga toxin-producing E. coli (STEC), especially O157:H7. The cornerstone of management for typical STEC-HUS is entirely supportive, focusing on rigorous fluid balance to maintain renal perfusion, electrolyte correction, and red blood cell transfusions if anemia is severe or symptomatic. The prior inappropriate use of a fluoroquinolone likely increased toxin release and precipitated the condition.

Step-by-Step Solution

1
Identify the classic triad in the clinical vignette.
The patient has microangiopathic hemolytic anemia (schistocytes, jaundice, low hemoglobin), thrombocytopenia (petechiae), and acute kidney injury (oliguria, elevated BUN/creatinine).
Recognizing this triad is essential for diagnosing the underlying syndrome.
2
Correlate the triad with the recent history.
The recent bloody diarrhea establishes the diagnosis of typical Hemolytic Uremic Syndrome (HUS), most commonly caused by Shiga toxin-producing E. coli (STEC).
Differentiating typical (diarrhea-associated) HUS from atypical HUS or TTP dictates specific management.
3
Evaluate the impact of the prior antibiotic administration.
The prior ciprofloxacin treatment likely exacerbated the condition, as antibiotics increase Shiga toxin release from dying bacteria.
Understanding the harm of antibiotics in this context reinforces why further pharmacologic intervention may be detrimental.
4
Determine the standard of care for typical pediatric STEC-HUS.
Management is purely supportive, prioritizing intravenous fluid expansion (which protects renal perfusion), electrolyte management, and packed red blood cell transfusions if anemia is severe or symptomatic.
Invasive or specific targeted therapies like plasmapheresis or platelet transfusions are either ineffective or actively harmful in typical STEC-HUS.

Key Concept

Typical (STEC-associated) Hemolytic Uremic Syndrome (HUS) is managed with supportive care, particularly volume expansion and monitoring. Antibiotics and platelet transfusions are generally contraindicated as they can exacerbate the microangiopathic process.
Rate this question